INFUSYSTEM HOLDINGS, INC Deferred Income Tax Assets, Net
INFUSYSTEM HOLDINGS, INC (INFU) had Deferred Income Tax Assets, Net of $3.58 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-08-04
- 2026-06-30: Deferred Income Tax Assets, Net $3.58M.
- 2026-03-31: Deferred Income Tax Assets, Net $4.23M.
- 2025-12-31: Deferred Income Tax Assets, Net $4.64M.
- 2025-09-30: Deferred Income Tax Assets, Net $4.81M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2026-06-30 | $3.58M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $4.23M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $4.64M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $4.81M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $5.96M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $6.75M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $7.19M 10-K · filed 2026-02-27 |
| 2024-09-30 | $7.82M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $8.64M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $9.24M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $9.12M 10-K · filed 2025-03-11 |
| 2023-09-30 | $9.24M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $9.74M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $9.99M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $9.63M 10-K · filed 2024-04-10 |
| 2022-09-30 | $9.94M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $10.19M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $10.28M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $10.03M 10-K · filed 2023-03-16 |
| 2021-09-30 | $10.82M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $10.61M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $10.15M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $9.97M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |